The National Institute of Minority Health and Health Disparities (NIMHD) welcomes applications for its Health Disparities Pre-Application (HDPreApp) Program for its spring 2024 cohort. This cohort will focus on SBIR/STTR applicants that are planning to resubmit an application for a previously submitted health disparities focused concept.
Applicants accepted into the HDPreApp cohort will be responsible for writing and preparing their application. NIMHD’s HDPreApp is implemented by RTI International, under contract with NIH. Recommendations from RTI do not represent the views of NIH or NIH staff.
*The NIMHD recognized health disparity populations include Hispanics/Latinos, rural areas, American Indians/Alaska Natives, sexual/gender, minorities, socioeconomically disadvantaged individuals, African Americans/Blacks, Native Hawaiians and Other Pacific Islanders, Asians, and people living with disabilities.
The first 2024 application window is currently open, and applications will be accepted on a rolling basis until Monday, April 15, 2024, then rolling afterwards. Businesses can apply to the HDPreApp Program on the NIMHD website.
This NOFO encourages applications from institutions that propose to establish research experiences in kidney technology development. Successful programs should include a collaborative capstone research or design project(s), innovative and/or ground-breaking technology development, multidisciplinary/interdisciplinary teamwork, education in entrepreneurship, product development and navigating regulatory pathways, and clinical immersion.
Applications must include plans to recruit undergraduate students as participants and to engage students from engineering and other quantitative scientific and technical backgrounds, but applicants may also propose the inclusion of medical students, graduate students and/or dual-degree students (e.g., M.D./Ph.D.; Pharm.D./Ph.D.) prior to their qualifying exams and selection of Ph.D. mentor.
Letter of Intent Deadline: Monday, May 13, 2024
Application Deadline: Thursday, June 13, 2024
NIDA released a new funding opportunity that is soliciting proposals for artificial intelligence and machine learning (AI/ML) tools to identify pharmacotherapeutic development candidates with lower toxicity and higher efficacy, specifically to prevent or treat substance use disorders (SUDs). Contact NIDASBIR@nih.gov if you are interested in a technical assistance meeting with a program officer.
Application Deadline: Thursday, July 25, 2024
|